Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors

Trending...
~ Veeva Systems, a leading cloud software company for the life sciences industry, has announced a major advancement in clinical trial execution with the latest release of Veeva Site Connect. This new release includes powerful capabilities and a streamlined site-centric experience to simplify and standardize sponsor-site collaboration.

According to Veeva, this new release will significantly reduce the time and effort required for site start-up, study conduct, and closeout. This will result in higher-quality trials at a lower cost for sponsors.

One of the key features of Veeva Site Connect is its ability to provide easy access to all necessary information for sites in just a few clicks. By standardizing how information is shared across all sites in one application, Veeva aims to save time and effort that can be focused on treating patients.

A clinical operations excellence leader at a top 20 biopharmaceutical company stated, "Our goal is to eliminate manual handoffs and inefficiencies for faster site start-up, more efficient monitoring, and simplified study closeout."

To achieve better trial execution in less time, Veeva Site Connect has expanded its capabilities beyond document exchange and safety distribution. It now includes Study Communications, Contacts, Payment Information, and quick links to sponsor systems.

More on Boston Chron
The user interface for sites has also been optimized with an intuitive homepage and simple sidebar navigation. This means that sites can easily stay informed and complete tasks with just a few clicks. Additionally, having the same user experience for all trials allows for a standard way of working across sponsors.

Veeva Site Connect is accessible for all sites globally. Sites that use Veeva SiteVault as their electronic Investigator Site File (eISF) will also benefit from seamless bidirectional document exchange.

With a fixed fee engagement of two to four months (depending on company size), sponsors can quickly implement Veeva Site Connect and make significant progress towards their goal of faster, higher quality trial execution.

Alisha Garibaldi, CEO of Skylight Health Research, expressed her enthusiasm for Veeva Site Connect, stating, "I would be ecstatic if all our sponsors use Veeva Site Connect. It gives sites a much more efficient way to collaborate with sponsors, maintain regulatory compliance, and get critical therapies to patients faster."

Marta Jureczko-Hinzmann, head of global clinical solution services at AstraZeneca, also shared her excitement for the new release. She stated, "By implementing Veeva Site Connect for our safety letter distribution process, we anticipate achieving a significant reduction in manual processing while enhancing oversight and compliance."

More on Boston Chron
Veeva Site Connect is part of Veeva Clinical Platform, a complete and connected solution that supports patients, sites, and sponsors. As the industry moves towards simplifying and standardizing site collaboration, seven of the top 20 biopharmaceutical companies have already adopted Veeva Site Connect to streamline their trials.

To learn more about Veeva Site Connect and see a demo of its capabilities, interested parties can attend the Veeva R&D and Quality Summit on September 9-10 in Boston. At this event, top biopharmaceutical companies will share how they use Veeva Site Connect to simplify trial execution for greater quality and speed.

For additional information on Veeva Site Connect, visit veeva.com/VeevaSiteConnect or connect with Veeva on LinkedIn at linkedin.com/company/veeva-systems.

About Veeva Systems:

Veeva Systems is a global leader in cloud software for the life sciences industry. With a commitment to innovation, product excellence, and customer success, Veeva serves over 1,000 customers ranging from large biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation (PBC), Veeva is dedicated to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Filed Under: Business
Show All News | Report Violation

0 Comments

Latest on Boston Chron